Decreasing relapse in colorectal cancer patients treated with cetuximab by using the activating KRAS detection chip

Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer

(2014) Ganepola AP Ganepola   World Journal of Gastrointestinal Oncology

Involvement of store-operated calcium signaling in EGF-mediated COX-2 gene activation in cancer cells

(2011) Jaw-Yuan Wang et al.   CELLULAR SIGNALLING

Prospective analysis of KRAS wild-type patients with metastatic colorectal cancer using cetuximab plus FOLFIRI or FOLFOX4 treatment regimens

(2011) M.Y. Huang et al.   GENETICS AND MOLECULAR RESEARCH

Activating KRAS Mutations and Overexpression of Epidermal Growth Factor Receptor as Independent Predictors in Metastatic Colorectal Cancer Patients Treated With Cetuximab

(2010) Li-Chen Yen et al.   ANNALS OF SURGERY

Socioeconomic position and participation in colorectal cancer screening

(2010) B L Frederiksen et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Enhancing Detection of Circulating Tumor Cells with Activating KRAS Oncogene in Patients with Colorectal Cancer by Weighted Chemiluminescent Membrane Array Method

(2009) Ming-Je Yang et al.   ANNALS OF SURGICAL ONCOLOGY

Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer

(2009) L.-C. Yen et al.   CLINICAL CANCER RESEARCH

The Role of Targeted Therapy in the Treatment of Advanced Colorectal Cancer

(2009) Marwan Fakih   CURRENT TREATMENT OPTIONS IN ONCOLOGY

A fast and convenient new technique to detect the therapeutic target, K-ras mutant, from peripheral blood in non-small cell lung cancer patients

(2009) Der-An Tsao et al.   LUNG CANCER

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group

(2008) D. Arnold et al.   ANNALS OF ONCOLOGY

KRASMutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab

(2008) Astrid Lièvre et al.   JOURNAL OF CLINICAL ONCOLOGY